Bizarre Patents
System for magnetically attaching templeless eyewear to a person
A system of eyewear that eliminates the need for hinges on the frames of the eyewear.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7615575 | Compounds for the treatment of metabolic disorders Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, artherosclerosis and arteriosclerosis are disclosed. Formula (I) wherein n is 1 or 2; m is 0, 1, 2,... | 11/10/2009 |
| 7446129 | Benzylated PDE4 inhibitors The present invention is directed to a method for reducing the emetogenic effects of PDE inhibitors, and more particularly is directed to compounds having PDE4 inhibition activity with little or no emetogenic side-effects, and chemical methods including benzylation ... | 11/04/2008 |
| 7329703 | Polymerized macrocyclic oligomer nanocomposite compositions The invention relates to polymers derived from macrocyclic oligomers containing organo clay fillers comprising a) a polymer derived from a macrocyclic oligomer; b) clay platelets; and c) the residue of one or more onium compounds having at least one ligand with a C | 02/12/2008 |
| 7279597 | Phenyl amine carboxylic acid compounds and compositions for delivering active agents Phenyl amine carboxylic acid compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well. ... | 10/09/2007 |
| 7273863 | Benzophenones as inhibitors of reverse transcriptase The present invention includes benzophenone compounds (I) which are useful in the treatment of HIV infections. ... | 09/25/2007 |
| 7217706 | Propanolamine derivatives This invention relates to new propanolamine derivatives or salts thereof represented by the following formula [I]: Wherein each symbol is as defined in the specification or salts thereof which have gut selective sympatho... | 05/15/2007 |
| 7208483 | Polymeric delivery agents and delivery agent compounds Polymeric delivery agents, delivery agent compounds and compositions comprising them which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well. ... | 04/24/2007 |
| 7129274 | Phenoxy carboxylic acid compounds and compositions for delivering active agents Phenoxy carboxylic acid compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well. ... | 10/31/2006 |
| 6960355 | Compounds and compositions for delivering active agents Modified amino acid compounds useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well. ... | 11/01/2005 |
| 6831099 | Enzyme inhibition Peptide-based compounds including heteroatom-containing, three-membered rings efficiently and selectively inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases. The activities of those Ntn having multiple activities can be differentially inhibited b... | 12/14/2004 |
| 6790979 | Curcumin analogues and uses thereof The present invention relates to compounds capable of acting as androgen receptor antagonists, pharmaceutical formulations containing the same, and methods of use thereof. Such uses include, but are not limited to, use as antitumor agents, particularly for the treat... | 09/14/2004 |
| 6780874 | Enamine derivatives Enamine derivatives of formula (1) are described: wherein R1 is a group Ar1L2Ar2Alk- in, which Ar1 is an aromatic or heteroaromatic group, L2 is a ... | 08/24/2004 |
| 6777443 | Dipeptide derivatives Compounds of the formula wherein R, R1, COOR2, R3-R7, alk, and X have meaning as defined, such being useful as dual inhibitors of angiotensin converting enzyme and neutral endo... | 08/17/2004 |
| 6610700 | Enamine derivatives Enamine derivatives of formula (1) are described: ##STR1## wherein R1 is a group Ar1 L2 Ar2 Alk- in which Ar1 is an aromatic or heteroaromatic group, L2 is a covalent bond or a linker atom ... | 08/26/2003 |
| 6495546 | Propanolamine derivatives Propanolamine derivatives represented by the following formula (I): ##STR1## These derivatives may be 댣 agonists and exert sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic and anti-urinary incontinence and anti-pollakiuria ac... | 12/17/2002 |
| 6455539 | Squaric acid derivates Squaric acid derivatives of formula (1) are described: ##STR1## wherein R1 is a group Ar1 Ar2 Alk- in which Ar1 is an optionally substituted aromatic or heteroaromatic group; Ar2 is an optionally substituted ph... | 09/24/2002 |
| 6420424 | CCR-3 receptor antagonists Phenylalanine sulfonamide derivatives and their use as CCR-3 receptor antagonist.... | 07/16/2002 |
| 6407100 | Fungicidal aromatic oximes The invention relates to novel compounds of the formula ##STR1## in which R1 is C1-4 alkyl and (Y--X) is CH2, C1-2 alkylthio-CH.dbd. or C1-2 alkyl-ON.dbd. and Z is an aldimino or ketimino group, and t... | 06/18/2002 |
| 6380249 | HIV integrase inhibitors Certain six-membered aromatic and heteroaromatic-dioxobutyric acid derivatives are described as inhibitors of HIV integrase and inhibitors of HIV replication. These compounds are useful in the prevention or treatment of infection by HIV and the treatment ... | 04/30/2002 |
| 6326399 | O-benzyloxime ethers and crop protection agents containing these compounds O-Benzyloxime ethers of the formula I ##STR1## where X is substituted or unsubstituted CH2, NOalkyl Y is O, S, NR5 R1, R2, R5 are H, alkyl Z1, Z2 are H, halogen, methyl, methoxy, cyano and... | 12/04/2001 |
| 6211212 | Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties A method of treatment of bacterial infections in humans or animals which comprises administering, in combination with a ଲ-lactam antibiotic, a therapeutically effective amount of an amino acid derivative or a pharmaceutically acceptable salt, solvat... | 04/03/2001 |
| 6207708 | Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors The current invention discloses hydroxyamidino derivatives useful as nitric oxide synthase inhibitors.... | 03/27/2001 |
| 6143776 | Tosylproline analogs as thymidylate synthase inhibitors Tosylproline analogs of formula I, methods of making them, pharmaceutical compositions containing them, and methods for their use. The compounds are thymidylate synthase inhibitors; and are useful as anti-tumor agents and as anti-parasitics, anti-bacteria... | 11/07/2000 |
| 6124329 | Metalloproteinase inhibitors Compounds of general formula (II) ##STR1## wherein R1, R2 and Z are defined in the claims, are matrix metalloproteinase inhibitors.... | 09/26/2000 |
| 6124333 | Metalloproteinase inhibitors Therapeutically active hydroxamic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, and the use of such compounds in medicine. The compounds are inhibitors of metalloproteinases involved in tissue degradation.... | 09/26/2000 |
| 6124332 | Metalloproteinase inhibitors Therapeutically active hydroxamic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, and the use of such compounds in medicine. The compounds are inhibitors of metalloproteinases involved in tissue degradation.... | 09/26/2000 |
| 5973006 | Fluoro-substituted benzoylpropionic acid derivatives A fluoro-substituted benzoylpropionic acid compound of formula (I) either as a single optical isomer or as a mixture of optical isomers ##STR1## wherein R is hydroxy, amino, hydroxylamine, --OR', --NHR', N(R')2 or --NHOR' in which R' is C | 10/26/1999 |
| 5965592 | Acyl compounds Compounds of the formula ##STR1## and their salts, in which R1, is a C1 -C7 aliphatic hydrocarbon radical; X1 is --CO; X2 is a divalent aliphatic hydrocarbon radical which comprises an ethyl grou... | 10/12/1999 |
| 5945091 | Photo-stable cosmetic and pharmaceutical formulations containing UV-filters A method of using compounds of formula I ##STR1## in which the C.dbd.C double bond is present in E and/or Z configuration and the variables have the following meanings: R1 denotes COOR5, COR5, CONR5 R6 | 08/31/1999 |
| 5919824 | Aminophenol derivatives Aminophenol derivatives represented by the following formula (1): ##STR1## wherein X is O or S; A is alkylene, R1 is phenyl, etc., R2 and R3 are H or alkyl; R4 is substituted carbamoylalkyl, etc.; R5 | 07/06/1999 |
| 5916922 | Phenyl glyoxamides as SPLA2 inhibitors A class of novel phenyl glyoxamides is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.... | 06/29/1999 |
| 5880160 | Colchicine derivatives, the use thereof and formulations containing them The present invention relates to novel colchicine derivatives having antiproliferative, antineoplastic, antiinflammatory and muscle relaxant activities; said derivatives include novel colchine nitrogen amides for use either as such or after derivatization... | 03/09/1999 |
| 5786379 | Adamantyl-substituted biaromatic compounds and pharmaceutical/cosmetic compositions comprised thereof Novel pharmaceutically/cosmetically-active adamantyl-substituted biaromatic compounds have the structural formula (I): ##STR1## wherein Ar is a radical having one of the formulae (a')-(f'): ##STR2## and are useful for the treatment of a wide var... | 07/28/1998 |
| 5776977 | Arylcycloalkyl derivatives, their production and their use Compounds of formula I, ##STR1## wherein the substituents R1 -R4 and a have the given meanings and show an activity against inflammatory conditions.... | 07/07/1998 |
| 5723459 | Biologically active acylated amino acid derivatives The present invention relates to novel compounds which possess a broad range of useful biological activities. These compounds can maintain, increase, or restore sensitivity of cells to therapeutic or prophylactic agents. They can also suppress, modify, or... | 03/03/1998 |
| 5708030 | Substituted kynurenines and process for their preparation The present invention relates to the use in the treatment of cognitive disorders associated with the aging processes of the brain and perinatal brain disorders of compounds which act as inhibitors of the enzyme kynurenine aminotransferase (KAT).... | 01/13/1998 |
| 5705529 | N-benzoyl amino acid derivatives pharmaceutical compositions containing them and process for preparing same The invention relates to novel N-benzoylamino acid derivatives of the general formula (I), ##STR1## wherein R1 and R2, which are the same or different, stand for a hydroxyl group optionally bearing an acetyl group; or a C1-... | 01/06/1998 |
| 5686492 | Disubstituted p-fluorobenzenesulfonamides Described herein are disubstituted p-fluorobenzenesulfonamides, containing a CF3 group, of general formula I ##STR1## which are suitable as NMR diagnostic agents.... | 11/11/1997 |
| 5629346 | Use of certain N-acetonylbenzamides as fungicides Certain N-acetonylbenzamides exhibit low toxicity to plants are particularly useful for control of fungi, especially Phycomycetes.... | 05/13/1997 |
| 5614555 | Amidinophenol derivatives Amidinophenol derivatives of the formula (I) ##STR1## wherein the various symbols are as defined herein; which have inhibitory activities on PLA2 and on various proteases such as trypsin, plasmin, thrombin, kallikrein, especially trypsin, ... | 03/25/1997 |
